Illinois Clinical Trials

Recruiting studies in Illinois

• LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
  NCT07415044PHASE2Eli Lilly and CompanyUlcerative Colitis (UC)Chicago, IL
• Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
  NCT06317649PHASE2National Cancer Institute (NCI)Acute Myeloid LeukemiaChicago, IL
• A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
  NCT06136650PHASE3Merck Sharp & Dohme LLCMetastatic Castration-resistant Prostate Cancer (mCRPC)Elmhurst, IL
• ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
  NCT07173751PHASE3BioNTech SEBreast NeoplasmsDecatur, IL
• A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
  NCT06972446PHASE2AbbVieRheumatoid ArthritisChicago, IL
• Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
  NCT07437950PHASE2National Cancer Institute (NCI)Acute Myeloid LeukemiaBloomington, IL
• A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
  NCT07100106PHASE1, PHASE2Genentech, Inc.Breast CancerZion, IL
• A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
  NCT07266402PHASE3Celldex TherapeuticsChronic Inducible UrticariaSkokie, IL
• Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
  NCT07392892PHASE2, PHASE3PfizerUntreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal AdenocarcinomaArlington Heights, IL
• A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
  NCT05828069PHASE2National Cancer Institute (NCI)Recurrent Langerhans Cell HistiocytosisChicago, IL
• Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
  NCT06393374PHASE3Merck Sharp & Dohme LLCTriple-Negative Breast CancerArlington Heights, IL
• Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
  NCT06136624PHASE3Merck Sharp & Dohme LLCProstate Cancer MetastaticChicago, IL

See all 2,621 recruiting trials →

Clinical trials by Illinois metro

• Chicago

Popular conditions in Illinois

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in Illinois?

Corterve aggregates actively recruiting clinical trials with sites in Illinois from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.

Are clinical trials in Illinois free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

What kinds of clinical trials are available in Illinois?

Illinois research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.